Related Experiment Videos
Insulin sensitivity and premenstrual syndrome
Kimberly K Trout1, Karen L Teff
1Monell Chemical Senses Center, 3500 Market Street, Philadelphia, PA 19104, USA. kteff@pobox.upenn.edu
Current Diabetes Reports
|July 22, 2004
Summary
Women with diabetes face challenges managing blood glucose. Premenstrual syndrome (PMS) may impact insulin sensitivity, but serotonin reuptuptake inhibitors may help regulate glucose levels.
Area of Science:
- Endocrinology
- Gynecology
- Metabolic Disorders
Background:
- Maintaining stable blood glucose is difficult for diabetic women.
- Menstrual cycle effects on glucose levels are debated.
- Premenstrual syndrome (PMS) may influence insulin sensitivity.
Purpose of the Study:
- Investigate the impact of the menstrual cycle on insulin sensitivity in diabetic women.
- Explore the role of PMS in conflicting study results.
- Assess the efficacy of serotonin reuptake inhibitors (SRIs) for managing PMS and improving glucose control.
Main Methods:
- Review existing studies on menstrual cycles and insulin sensitivity in diabetes.
- Analyze the potential confounding effect of PMS.
- Examine literature on SRI treatment for PMS and its metabolic effects.
Main Results:
- Conflicting data exists regarding menstrual cycle phase and insulin sensitivity in diabetic women.
- PMS may exacerbate variations in insulin sensitivity.
- SRIs show potential in alleviating PMS symptoms and improving glucose regulation.
Conclusions:
- PMS is a potential factor contributing to variability in insulin sensitivity during the menstrual cycle for diabetic women.
- SRI treatment may offer a dual benefit for PMS symptoms and glycemic control.
- Further research is warranted to clarify the complex interplay between the menstrual cycle, PMS, and diabetes management.